Device Bone Matrix Implant, Composite

Osteostrand Plus

Payments companies reported to CMS as associated with Osteostrand Plus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$403Kassociated payments (2023-2025)
79clinicians with associated payments
1company reporting

By year

2023 $197K
2024 $195K
2025 $11K

Payments reported as associated with Osteostrand Plus, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery of The Spine $392K
Orthopaedic Surgery $7,564
Neurological Surgery $2,583
Surgical $200
Vascular Surgery $143
Internal Medicine $131

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Osteostrand Plus

These are the largest totals companies reported as associated with Osteostrand Plus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Scott Boden Atlanta, GA Orthopaedic Surgery of The Spine $357,135.73
Raymond Hah Los Angeles, CA Orthopaedic Surgery of The Spine $10,687.93
Neelakantan Anand Los Angeles, CA Orthopaedic Surgery of The Spine $10,028.11
Scott Mcgovern Salisbury, MD Orthopaedic Surgery of The Spine $7,142.05
James Bruffey La Jolla, CA Orthopaedic Surgery $6,342.15
Harvinder Sandhu New York, NY Orthopaedic Surgery of The Spine $2,599.63
Michael Collins Metairie, LA Orthopaedic Surgery of The Spine $1,774.27
Najib El Tecle Chicago, IL Neurological Surgery $967.57
Gregory Mundis La Jolla, CA Orthopaedic Surgery of The Spine $750.00
Nolan Wessell Aurora, CO Orthopaedic Surgery of The Spine $416.25

Prescribed Osteostrand Plus?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.